Dr. Asmus brings two decades of experience leading global clinical and translational research programs for

Led by specialist life sciences investor, Forbion Investment will fund Phase 2 human clinical studies

Appointment builds Oxular’s team as it prepares to enter human clinical studies evaluating OXU-001 OXFORD,

Provides further momentum for OXU-003 development programme   OXFORD, England, Oct. 12, 2020 – Oxular Limited (“Oxular”),

Oxular Limited Appoints Dr. Rafiq Hasan as Non-Executive Director OXFORD, UK, 5 October 2020 –

Prof. Marc de Smet joins Oxular Prof. de Smet is a retinal surgeon with more

Abingdon, UK, 7 October 2016 – OBN Ltd, the membership organisation supporting the UK’s innovative

V-Bio Ventures joins investment syndicate Completes oversubscribed £15.5 million Series A financing round Accelerates development

22 February 2016 – Imperial Innovations Group plc (AIM: IVO, ‘the Group’, ‘Innovations’) has led